ArticleOpen medicine (Warsaw, Poland)2024

New target-HMGCR inhibitors for the treatment of primary sclerosing cholangitis: A drug Mendelian randomization study.

Jie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.